On March 27th, 2024, Prognos Health, GeneDx and Pharming hosted a webinar titled "Leveraging De-identified Real World Data to Shorten the Rare Disease Diagnostic Odyssey" featuring Amanda Singleton from GeneDx and Heather McLaughlan from Pharming. The webinar discussed how anonymized real-world data can expedite diagnoses for rare diseases. It explored the benefits of combining genetic and non-genetic data to create detailed patient profiles and addressed the challenges and advancements in diagnosing, treating, and monitoring rare diseases. Additionally, it highlighted the latest cutting-edge technologies and therapeutics used in this field. Watch the recorded webinar below and hear the immense passion and drive that the GeneDx and Pharming team are bringing to support those facing the huge challenges associated with being diagnosed and living with a rare disease.